Cabot (NYSE:CBT) Given New $80.00 Price Target at Mizuho

Cabot (NYSE:CBT) had its price objective increased by Mizuho from $75.00 to $80.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Mizuho currently has a neutral rating on the specialty chemicals company’s stock.

A number of other brokerages also recently issued reports on CBT. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. UBS Group raised their price objective on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $75.00.

Cabot Stock Up 4.2%

Shares of CBT opened at $82.28 on Wednesday. Cabot has a 52-week low of $58.33 and a 52-week high of $85.27. The company has a market capitalization of $4.30 billion, a PE ratio of 15.55, a price-to-earnings-growth ratio of 10.41 and a beta of 0.78. The stock has a fifty day simple moving average of $73.83 and a two-hundred day simple moving average of $70.35. The company has a quick ratio of 1.09, a current ratio of 1.67 and a debt-to-equity ratio of 0.49.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.28% and a net margin of 7.97%.The business had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. During the same period last year, the company earned $1.90 EPS. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, equities analysts forecast that Cabot will post 6.27 EPS for the current year.

Cabot Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a $0.4725 dividend. The ex-dividend date of this dividend is Friday, May 29th. This represents a $1.89 annualized dividend and a yield of 2.3%. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio is presently 31.52%.

Hedge Funds Weigh In On Cabot

Several hedge funds and other institutional investors have recently made changes to their positions in CBT. NewEdge Advisors LLC boosted its stake in shares of Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock valued at $82,000 after buying an additional 947 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after buying an additional 108,645 shares during the period. Empowered Funds LLC boosted its stake in shares of Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after buying an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after buying an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot News Roundup

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Q2 adjusted EPS beat consensus — Cabot reported adjusted EPS of $1.61 vs. the Zacks/Street estimate of $1.47, showing better-than-expected earnings execution despite tougher demand. Cabot (CBT) Surpasses Q2 Earnings Estimates
• Positive Sentiment: Dividend increase — the board raised the quarterly payout 5% to $0.4725 (annualized $1.89), supporting income-focused investor interest and signaling cash-flow confidence. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
• Positive Sentiment: Battery materials momentum — management flagged growing BESS and EV demand with meaningful EBITDA contribution from battery materials, a growth area that investors may value higher. Cabot Q2 Results & Remarks on Battery Materials
• Neutral Sentiment: FY2026 guidance largely in-line — Cabot set FY26 EPS guidance to $6.00–$6.50 (Street ~6.24), which is broadly consistent with expectations but leaves limited upside if execution slips. Cabot FY2026 Guidance Slide Deck
• Negative Sentiment: Top-line weakness and lower YoY EPS — revenue fell ~3.4% vs. last year and GAAP EPS declined from $1.90 to $1.61 (adjusted), pointing to softer end-market demand that could pressure margins if sustained. MarketBeat: Cabot Q2 Results
• Negative Sentiment: Planned asset optimization — Cabot intends to close certain manufacturing operations in South America and Europe, which may generate restructuring charges and short-term disruption even if it improves long-term competitiveness. Asset Optimization Announcement
• Negative Sentiment: Analyst stance shows caution — Mizuho raised its price target to $80 but maintained a Neutral rating (PT slightly below the current price), indicating limited near-term upside per that analyst. Mizuho Price Target Note

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.